LFVN Overview

LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.

Wall Street analysts forecast LFVN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LFVN is12.00 USD with a low forecast of 12.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

LifeVantage Corp revenue for the last quarter amounts to 48.93M USD, decreased -27.79

LifeVantage Corp. EPS for the last quarter amounts to 0.02 USD, decreased -89.47

LifeVantage Corp (LFVN) has 232 emplpoyees as of March 30 2026.

Today LFVN has the market capitalization of 55.01M USD.